胸腔镜治疗早期脓胸:这是黄金标准吗?

Journal of visualized surgery Pub Date : 2018-05-29 eCollection Date: 2018-01-01 DOI:10.21037/jovs.2018.05.18
Hany Hasan Elsayed, Ahmed Mostafa, Essam Fathy, Haytham S Diab, Ibrahim Mostafa Nofal, Osama Abbas AbdelHamid, Hatem Yazeed El-Bawab, Ahmed A ElNori
{"title":"胸腔镜治疗早期脓胸:这是黄金标准吗?","authors":"Hany Hasan Elsayed,&nbsp;Ahmed Mostafa,&nbsp;Essam Fathy,&nbsp;Haytham S Diab,&nbsp;Ibrahim Mostafa Nofal,&nbsp;Osama Abbas AbdelHamid,&nbsp;Hatem Yazeed El-Bawab,&nbsp;Ahmed A ElNori","doi":"10.21037/jovs.2018.05.18","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Empyema is a well-known disease that significantly increases the morbidity and mortality associated with pneumonia. There are a number of treatment modalities available but recently video assisted thoracoscopic surgery (VATS) has been suggested as a reliable tool in management of empyema; particularly in early stages. The aim of this study is to assess the safety and effectiveness of using initial VATS for all surgically fit patients with early stages of empyema.</p><p><strong>Methods: </strong>Sixty-six patients with early stage empyema were prospectively studied between December 2013 and March 2016. Patients were divided into two groups: group A (28 patients) were managed conservatively without surgery for stage I (exudative) phase empyema by the chest physicians; and group B (38 patients) were managed by the thoracic surgeons by VATS for stage I (exudative) and stage II (fibrino-purulent) empyema. Comparison was made between both groups.</p><p><strong>Results: </strong>There was no statistically significant difference between the groups from the point of view of age, sex or pre-intervention comorbidities (P>0.05). Average hospital stay in group A was 22 days (7-131 days), it was 4.1 days (2-14 days) in group B (P=0.004; 95% CI: 10.3-25.5) with a resultant lower cost. Three patients (10.7%) in group A suffered from major morbidity during treatment while none in group B suffered a major postoperative morbidity (P=0.039). There were 2 mortalities (7.1%) in group A and no deaths in group B (P=0.094). During a mean follow up period of 8 months [6-14] in group A 14.3% of the patients underwent open decortication, whereas in group B, 5.3% of the patients underwent the same procedure (P=0.047).</p><p><strong>Conclusions: </strong>Thoracoscopic management of early stages of empyema should be the golden standard of management in surgically fit patients; particularly in the fibro-exudative phase of empyema. It is an effective and safe technique that reduces hospital stay, cost, complications and avoids the need for a decortication via a thoracotomy in most cases.</p>","PeriodicalId":17587,"journal":{"name":"Journal of visualized surgery","volume":"4 ","pages":"114"},"PeriodicalIF":0.0000,"publicationDate":"2018-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/jovs.2018.05.18","citationCount":"15","resultStr":"{\"title\":\"Thoracoscopic management of early stages of empyema: is this the golden standard?\",\"authors\":\"Hany Hasan Elsayed,&nbsp;Ahmed Mostafa,&nbsp;Essam Fathy,&nbsp;Haytham S Diab,&nbsp;Ibrahim Mostafa Nofal,&nbsp;Osama Abbas AbdelHamid,&nbsp;Hatem Yazeed El-Bawab,&nbsp;Ahmed A ElNori\",\"doi\":\"10.21037/jovs.2018.05.18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Empyema is a well-known disease that significantly increases the morbidity and mortality associated with pneumonia. There are a number of treatment modalities available but recently video assisted thoracoscopic surgery (VATS) has been suggested as a reliable tool in management of empyema; particularly in early stages. The aim of this study is to assess the safety and effectiveness of using initial VATS for all surgically fit patients with early stages of empyema.</p><p><strong>Methods: </strong>Sixty-six patients with early stage empyema were prospectively studied between December 2013 and March 2016. Patients were divided into two groups: group A (28 patients) were managed conservatively without surgery for stage I (exudative) phase empyema by the chest physicians; and group B (38 patients) were managed by the thoracic surgeons by VATS for stage I (exudative) and stage II (fibrino-purulent) empyema. Comparison was made between both groups.</p><p><strong>Results: </strong>There was no statistically significant difference between the groups from the point of view of age, sex or pre-intervention comorbidities (P>0.05). Average hospital stay in group A was 22 days (7-131 days), it was 4.1 days (2-14 days) in group B (P=0.004; 95% CI: 10.3-25.5) with a resultant lower cost. Three patients (10.7%) in group A suffered from major morbidity during treatment while none in group B suffered a major postoperative morbidity (P=0.039). There were 2 mortalities (7.1%) in group A and no deaths in group B (P=0.094). During a mean follow up period of 8 months [6-14] in group A 14.3% of the patients underwent open decortication, whereas in group B, 5.3% of the patients underwent the same procedure (P=0.047).</p><p><strong>Conclusions: </strong>Thoracoscopic management of early stages of empyema should be the golden standard of management in surgically fit patients; particularly in the fibro-exudative phase of empyema. It is an effective and safe technique that reduces hospital stay, cost, complications and avoids the need for a decortication via a thoracotomy in most cases.</p>\",\"PeriodicalId\":17587,\"journal\":{\"name\":\"Journal of visualized surgery\",\"volume\":\"4 \",\"pages\":\"114\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.21037/jovs.2018.05.18\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of visualized surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/jovs.2018.05.18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of visualized surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/jovs.2018.05.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

摘要

背景:脓胸是一种众所周知的疾病,可显著增加与肺炎相关的发病率和死亡率。有许多可用的治疗方式,但最近视频辅助胸腔镜手术(VATS)已被建议作为一种可靠的工具,在管理脓胸;尤其是在早期阶段。本研究的目的是评估初始VATS用于所有早期脓胸手术患者的安全性和有效性。方法:对2013年12月至2016年3月66例早期脓胸患者进行前瞻性研究。患者分为两组:A组(28例)由胸科医生保守治疗I期(渗出性)脓胸,不进行手术治疗;B组(38例)由胸外科医生对I期(渗出性)和II期(纤维蛋白化脓性)脓胸进行VATS治疗。两组进行比较。结果:两组患者年龄、性别及干预前合并症比较,差异均无统计学意义(P>0.05)。A组平均住院时间为22天(7 ~ 131天),B组平均住院时间为4.1天(2 ~ 14天)(P=0.004;95% CI: 10.3-25.5),从而降低了成本。A组3例(10.7%)患者在治疗过程中出现重大并发症,B组无患者术后出现重大并发症(P=0.039)。A组有2例死亡(7.1%),B组无死亡(P=0.094)。在平均8个月的随访期间[6-14],a组14.3%的患者进行了开放式去皮,而B组5.3%的患者进行了相同的手术(P=0.047)。结论:胸腔镜治疗早期脓胸应成为适合手术患者治疗的金标准;特别是在脓胸的纤维渗出期。这是一种有效和安全的技术,可减少住院时间、费用、并发症,并避免在大多数情况下通过开胸手术进行去皮。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Thoracoscopic management of early stages of empyema: is this the golden standard?

Background: Empyema is a well-known disease that significantly increases the morbidity and mortality associated with pneumonia. There are a number of treatment modalities available but recently video assisted thoracoscopic surgery (VATS) has been suggested as a reliable tool in management of empyema; particularly in early stages. The aim of this study is to assess the safety and effectiveness of using initial VATS for all surgically fit patients with early stages of empyema.

Methods: Sixty-six patients with early stage empyema were prospectively studied between December 2013 and March 2016. Patients were divided into two groups: group A (28 patients) were managed conservatively without surgery for stage I (exudative) phase empyema by the chest physicians; and group B (38 patients) were managed by the thoracic surgeons by VATS for stage I (exudative) and stage II (fibrino-purulent) empyema. Comparison was made between both groups.

Results: There was no statistically significant difference between the groups from the point of view of age, sex or pre-intervention comorbidities (P>0.05). Average hospital stay in group A was 22 days (7-131 days), it was 4.1 days (2-14 days) in group B (P=0.004; 95% CI: 10.3-25.5) with a resultant lower cost. Three patients (10.7%) in group A suffered from major morbidity during treatment while none in group B suffered a major postoperative morbidity (P=0.039). There were 2 mortalities (7.1%) in group A and no deaths in group B (P=0.094). During a mean follow up period of 8 months [6-14] in group A 14.3% of the patients underwent open decortication, whereas in group B, 5.3% of the patients underwent the same procedure (P=0.047).

Conclusions: Thoracoscopic management of early stages of empyema should be the golden standard of management in surgically fit patients; particularly in the fibro-exudative phase of empyema. It is an effective and safe technique that reduces hospital stay, cost, complications and avoids the need for a decortication via a thoracotomy in most cases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信